Stephen D. Griffin - 03 Jun 2025 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
EVP, CFO & COO
Signature
/s/ Stephen D. Griffin
Issuer symbol
ANIK
Transactions as of
03 Jun 2025
Net transactions value
-$43,683
Form type
4
Filing time
05 Jun 2025, 17:01:13 UTC
Previous filing
18 Mar 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Griffin Stephen D. EVP, CFO & COO 32 WIGGINS AVENUE, BEDFORD /s/ Stephen D. Griffin 05 Jun 2025 0001831125

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Options Exercise $0 +12,840 +1605% $0.000000 13,640 03 Jun 2025 Direct F1, F2
transaction ANIK Common Stock Tax liability $43,683 -3,769 -28% $11.59 9,871 03 Jun 2025 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Options Exercise $0 +12,840 +100% $0.000000 25,680 03 Jun 2025 Common Stock 12,840 $0.000000 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the first vesting installment of RSUs granted on June 3, 2024.
F2 Includes 800 shares acquired on May 14, 2025 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan.
F3 Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2025.
F4 Reflects the closing price of ANIK common stock on June 3, 2025, the trading date on which the vesting of RSUs gave rise to tax withholding obligations.
F5 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025.